Company / Debt per Share
10x Genomics, Inc. Debt per Share History
FY2018-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Debt per Share
-
FY2020
5-year range
-
FY2018-FY2020
Trend
-100.0%
vs FY2019
Sector context
#99 of 100
Health Care
What the data says
Improved from $1.90 to $0.00 over the past 2 years.
Health Care sector context is included.
Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 1% in Health CareTop 1% of 100
▼
Key checks
Key Insights
- In FY2020, debt per share decreased 100.0% year-over-year.
Company context
Key Data Points
- Altman Z-Score 0.94 (distress zone, below 1.8 threshold)
- Negative profit margin: -29.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | $0.00 | -100.0% |
| FY2019 | $2.04 | +7.3% |
| FY2018 | $1.90 | - |
| FY2017 | - | - |
As of FY2020 · SEC 10-K · Updated Feb 28, 2026